rs3024886

This is a downstream gene variant variant in the STAT4 gene.

▶

GWAS Catalog Trait Associations (1)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

▶

Research that mentions this SNP (1)

▶
High‐density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups
AssociationN=9,234Namjou B. et al.(2009)· Arthritis &amp; Rheumatism

A large case-control study of 4,374 SLE cases and 4,860 controls from multiple racial/ethnic groups identified strong genetic associations between multiple SNPs in the STAT4 gene and systemic lupus erythematosus (SLE), with the strongest association at rs10168266 (p=1.38×10⁻¹⁵ in Europeans, combined p=7.02×10⁻²⁵). Multiple significant haplotypes spanning the STAT4 gene were found across European, Asian-Korean, Hispanic, and African American populations, with conditional analyses suggesting rs10168266 explains the primary haplotypic association. In contrast, STAT1 showed only weak suggestive associations.

Traits studied:Primary Sjögren's syndromeRheumatoid arthritisSystemic lupus erythematosus
PubMedDOIMetascience Observatory

About STAT4

The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is essential for mediating responses to IL12 in lymphocytes, and regulating the differentiation of T helper cells. Mutations in this gene may be associated with systemic lupus erythematosus and rheumatoid arthritis. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2011]

View all STAT4 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…